AC
BIIB icon

Arjuna Capital’s Biogen BIIB Stock Holding History

Arjuna Capital’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-3,772
Closed -$969K – 99
2023
Q3 		$969K Buy
3,772
+116
+3% +$31K 0.35% 72
2023
Q2 		$1.04M Buy
3,656
+204
+6% +$60.7K 0.37% 71
2023
Q1 		$960K Buy
+3,452
New +$955K 0.38% 72
2020
Q4 		– Sell
-2,792
Closed -$792K – 96
2020
Q3 		$792K Sell
2,792
-4,354
-61% -$1.21M 0.49% 56
2020
Q2 		$1.91M Buy
7,146
+85
+1% +$25.6K 1.32% 27
2020
Q1 		$2.23M Buy
7,061
+4,820
+215% +$1.46M 1.86% 16
2019
Q4 		$665K Buy
+2,241
New +$622K 0.48% 55
2019
Q2 		– Sell
-2,795
Closed -$661K – 94
2019
Q1 		$661K Buy
+2,795
New +$880K 0.51% 60

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Arjuna Capital's BIIB Position: Q4 2023 in Review

Arjuna Capital sold out of Biogen (BIIB) in Q4 2023, closing a stake of 3,772 shares — an estimated $969K sold.

Arjuna Capital first reported a position in BIIB in Q1 2019 and held it in 8 quarters. The position peaked at $2.23M in Q1 2020. 1,003 funds tracked by Wall St. Rank hold BIIB as of Q4 2023.

  • Arjuna Capital reported no remaining Biogen position as of Q4 2023 after selling out during the quarter.
  • Arjuna Capital sold 3,772 Biogen shares in Q4 2023, an estimated $969K.
  • Arjuna Capital first reported a position in Biogen in Q1 2019 and held it in 8 quarters.
  • Arjuna Capital's Biogen position peaked at $2.23M in Q1 2020.
  • 1,003 funds tracked by Wall St. Rank held Biogen as of Q4 2023.

Based on Arjuna Capital's 13F filing for Q4 2023, filed 8 Feb 2024.